Dr Kriti Kaushik

Medical Advisor for Emerging markets :

• Provided medical expertise across therapeutic areas such as cardiology, diabetology, urology, pain management, nutrition etc based on the brands/products of Dr Reddys available in the respective countries for both B-B and B-C models.

Medical Advisor for Oral Care:

• Provided medical strategies for the therapy area specially for the focused brands and new launch products
• Collaboration with marketing team in preparation of promo material, scientific communication, project proposals
• Evidence generation and other allied activities and support for major brands.

Medical Advisor for Oral Care and Dermatology:

• Currently handling both the therapies
• Collaboration with marketing, sales and other cross functional teams for effective delivery of medical strategy required for the development of the brand
• Medical educations such as Ad boards, CME's etc are driven on a regular basis for dissipation of science
• Evidence generation and collaboration with societies for development of guidelines and other projects for better HCP awareness

• A part of the launch team of Shingrix (Recombinant Zoster vaccine, non-live, adjuvanted)
• Many promotional activities conducted to support the launch of the vaccine in India
• Multiple training programs conducted for the sales force as well as for the nurses as a part of vaccine awareness
• Multiple congresses participated to deliver to knowledge about the vaccine

• Handled the gram positive and gram negative antibiotic portfolio, including the innovator molecule Ceftaroline fosamil
• Conducted scientific and clinical presentations to facilitate medical education strategy
• Leveraged clinical and scientific data to optimize delivery of integrated brand plans
• Established relationships with external customers to gain insights into decision-making and brand strategy development
• Collaborated with cross-functional teams to support product marketing access strategy
• Presented research posters at conferences: CRITICARE 2022 and CIDSCON 2022
• Promoted scientific and clinical trends awareness and maintained understanding of scientific evidence to construct accurate knowledge
• Scrutinized promotional materials for medical accuracy and compliance with guidelines and regulations

• As a part of team 'NCE (New Chemical Entity)', launched 'Levonadifloxacin' first antibiotic that is researched and developed in India
• Played a key role in harboring collaborative relations with key opinion leaders (KOLs) creating a platform for scientific information exchange with company
• Assisted in development and progression of various projects and investigator initiated (IIS) studies for NCEs